Protein Engineering Market By Product Type (Modified Enzymes, Insulin, Monoclonal Antibodies, Coagulation Factors, Vaccines, Growth Factors, and Other Product Types), By Technology (Irrational Protein Design, and Rational Protein Design), By End User (Pharmaceutical and Biotechnology Companies, Academic Institutions, and Contract Research Organizations), and By Region- Trends, Analysis and Forecast till 2030

Protein Engineering Market accounted for USD 2.43 Billion 2020 and is estimated to be USD 7.22 Billion by 2030 and is anticipated to register a CAGR of 11.5%.

Protein engineering is the manipulation of the structures of proteins to produce the desired properties or the synthesis of proteins with particular structures. It is the process by which novel proteins with desired properties are developed and has grown enormously since the past three decades. In the past years, protein engineers have successfully generated a wide range of proteins tailored to specific health, industry, medicine, research, and biotechnology applications. Protein designing and coordinated development are incredible advancements for examining protein grouping capacity connections. These strategies have been utilized to design both plant-inferred proteins and exogenous proteins heterologously communicated in plants. In this survey, we expect to additional expansion the interdisciplinary hybrid between the disciplines of protein designing and plant science by first presenting protein designing in some detail. This acquaintance is key with understanding current restrictions to protein designing when applied to plants. Consequently, we give an outline of the new methodological advancement in, and novel utilizations of, protein designing and coordinated development in plant research. 

The propelling factors for the growth of the protein engineering market include the increasing prevalence of protein-deficient diseases, increase in adoption of protein drugs over non-protein drugs. In addition, increased demand for alternatives to chemical processes, and rising government funding for protein engineering will further boost the growth of target market.  Factors such as the increasing investments in synthetic biology and the growing focus on protein-based drug development by pharmaceutical and biotechnology companies are expected to drive the growth of the protein engineering market.  The high prevalence rate of lifestyle diseases along with growth in funding for protein engineering, high cost of tools and instruments used in protein engineering techniques are the factors that drive the growth of the global market. The demand of protein engineering developing countries coupled with the preference of protein therapy over gene therapy along with the expiry of blockbuster biologics drugs in the near future. Protein engineering also holds immense opportunity in the agrochemical industry as engineering in proteins may lead to the generation of enzymes with an improved function that may increase the crop yield or facilitate biofuel production. It is also likely to play an important role as a tool to attain increased crop yield needed to meet future demands. A number of qualified researchers are the factors that offer abundant growth opportunities in the market. However, factors such as the high cost of instruments and laboratory documentationfv systems are expected to restrain the growth of the global market during the forecast period.

Protein engineering market is segmented based on product type, technology, end-user, and region.

Based on product type, the protein engineering market is segmented into the modified enzymes, insulin, monoclonal antibodies, coagulation factors, vaccines, growth factors, and other product types. Monoclonal antibodies are anticipated to hold the largest market share in the future, owing to their high adoption for numerous therapies, such as cancer and autoimmune diseases. Based on the technology, the target market is segmented into irrational protein design, and rational protein design. The rational protein design segment accounted for the largest share of the market in 2019. The large share of this segment can be attributed to the increasing use and continuous upgrades of bioinformatics platforms and software for protein analysis. Based on end user, the target market is bifurcated into pharmaceutical and biotechnology companies, academic institutions, and contract research organizations. The biopharmaceutical companies segment accounted for the largest share of the market in 2019. This is because protein engineering products are widely used for drug discovery and development by biopharmaceutical companies, as they help in designing models to develop a broad range of protein-based drugs.

Based on the region the protein engineering market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market in North America accounted for the largest share of the global market, closely followed by Europe. Factors such as the presence of well-established CROs, rising R&D expenditure, and the availability of the latest techniques and instruments for drug discovery research are responsible for the large share of the North American market. Asia Pacific protein engineering market is projected to register a high CAGR over the forecast period owing to the growing presence of contract research organizations, rising healthcare IT spending, and unprecedented evolution of the healthcare infrastructure and standards across this region. 

Protein Engineering Market, By Product Type:

• Modified Enzymes
• Insulin
• Monoclonal Antibodies
• Coagulation Factors
• Vaccines
• Growth Factors
• Other Product Types

Protein Engineering Market, By Technology:

• Irrational Protein Design
• Rational Protein Design

Protein Engineering Market, By End User:

• Pharmaceutical and Biotechnology Companies
• Academic Institutions
• Contract Research Organizations

Protein Engineering Market, By Region:

• North America
  • Middle East & Africa
    • Middle East & Africa Protein Engineering Market, By Product Type
    • Middle East & Africa Protein Engineering Market, By Technology
    • Middle East & Africa Protein Engineering Market, By End User
    • Middle East & Africa Protein Engineering Market, By Country
      • GCC
      • Israel
      • South Africa
      • Rest of Middle East & Africa
  • Latin America
    • Latin America Protein Engineering Market, By Product Type
    • Latin America Protein Engineering Market, By Technology
    • Latin America Protein Engineering Market, By End User
    • Latin America Protein Engineering Market, By Country
      • Brazil
      • Mexico
      • Rest of Latin America
  • Asia Pacific
    • Asia Pacific Protein Engineering Market, By Product Type
    • Asia Pacific Protein Engineering Market, By Technology
    • Asia Pacific Protein Engineering Market, By End User
    • Asia Pacific Protein Engineering Market, By Country
      • China
      • India
      • Japan
      • South Korea
      • Rest of Asia Pacific
  • Europe
    • Europe Protein Engineering Market, By Product Type
    • Europe Protein Engineering Market, By Technology
    • Europe Protein Engineering Market, By End User
    • Europe Protein Engineering Market, By Country
      • Germany
      • UK
      • France
      • Russia
      • Italy
      • Rest of Europe
  • North America Protein Engineering Market, By Product Type
  • North America Protein Engineering Market, By Technology
  • North America Protein Engineering Market, By End User
  • North America Protein Engineering Market, By Country
    • U.S.
    • Canada

The key players operating the protein engineering market involves Thermo Fisher Scientific, Danaher Corporation, Agilent Technologies, Bio-Rad Laboratories, Amgen Inc., Bruker Corporation, General Electric, Perkinelmer, Inc, Genscripts Usa, Inc., and Sigma-Aldrich Corporation. Prominent players operating in the target market are focusing on strategic partnerships as well as the launching of the products to gain a competitive edge in the target market. For instance, in July 2019, Amgen and the University of Washington's Institute for Protein Design (IPD), which is revolutionizing its field of science by creating custom-designed proteins from scratch to improve human health, today announced a broad collaboration that will cover multiple projects with a goal of testing new technologies and creating protein-building approaches that can be broadly applied to the search for new medicines.

• Thermo Fisher Scientific
• Danaher Corporation
• Agilent Technologies
• Bio-Rad Laboratories
• Amgen Inc.
• Bruker Corporation
• General Electric
• PerkinElmer, Inc.
• Genscripts USA, Inc.
• Sigma-Aldrich Corporation.